department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

MEROPENEM · pharmadog

pharmadog
drugs
MEROPENEM

drug

patient view →

MEROPENEM

Marketedupdated 2mo ago

by Savior Lifetec Corp

Approved

community read0 votes

all catalysts(10)

approval · 10

MEROPENEM — FDA approval

MEROPENEM — FDA approval

MEROPENEM — FDA approval

MEROPENEM — FDA approval

MEROPENEM — FDA approval

MEROPENEM — FDA approval

MEROPENEM — FDA approval

MEROPENEM — FDA approval

MEROPENEM — FDA approval

MEROPENEM — FDA approval

view all 10 catalysts →

News(0)

no news has mentioned this drug yet

brand

MEROPENEM

generic

MEROPENEM

indication

Bacterial (Pyogenic) Meningitis

phase

marketed

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

openFDA · ClinicalTrials.gov

last refreshed 11m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 8

tagApproval38 co-mentions · 19 sources
drugMeropenem HQ21 co-mentions · 21 sources
drug(meropenem + vaborbactam)6 co-mentions · 6 sources
companySavior Lifetec Corp4 co-mentions · 4 sources
companyACS Dobfar SpA4 co-mentions · 4 sources
drugpolymyxin B1 co-mentions · 1 sources
tagRecall1 co-mentions · 1 sources
company$TMOTHERMO FISHER SCIENTIFIC INC.1 co-mentions · 1 sources

Trials studying MEROPENEM

phase2Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacterianot yet recruitingn=48
phase2PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONINcompletedn=100
phase3A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABPrecruitingn=420
phase2A Study to Assess How Vaborem® is Taking up in the Body and Tolerated in Paediatric Patients With Gram Negative Infections, Including But Not Restricted to Complicated Urinary Tract Infectionsrecruitingn=44
phase3Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complexnot yet recruitingn=248
phase2A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritisrecruitingn=66
phase1Evaluation of the Concentration of ANT3310 and Meropenem in the Lung in Healthy Adult Participantscompletedn=26
phase3Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)completedn=530

more trials →